NCT00963365View on ClinicalTrials.gov

AZD6765 Oral Single Ascending Dose/Multiple Ascending Dose (SAD/MAD)

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

November 30, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

March 31, 2010

Conditions

Healthy

Interventions

DRUG

AZD6765

Single oral dose and single IV infusion of AZD6765

DRUG

AZD6765

Once-daily oral dose of AZD6765 or placebo on Day 1 and on Days 4 through 9.

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY